Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Molecular Epidemiology of Dengue in Panama: 25 Years of Circulation.

Díaz Y, Chen-Germán M, Quiroz E, Carrera JP, Cisneros J, Moreno B, Cerezo L, Martinez-Torres AO, Moreno L, Barahona de Mosca I, Armién B, Chen R, Vasilakis N, López-Vergès S.

Viruses. 2019 Aug 20;11(8). pii: E764. doi: 10.3390/v11080764.

2.

HLA Upregulation During Dengue Virus Infection Suppresses the Natural Killer Cell Response.

McKechnie JL, Beltrán D, Pitti A, Saenz L, Araúz AB, Vergara R, Harris E, Lanier LL, Blish CA, López-Vergès S.

Front Cell Infect Microbiol. 2019 Jul 23;9:268. doi: 10.3389/fcimb.2019.00268. eCollection 2019.

3.

Zika Virus-Associated Cerebellitis with Complete Clinical Recovery.

Pachar MR, Araúz D, Gundacker ND, Suárez M, Suárez JA, Moreno B, López-Vergès S, Araúz AB.

Am J Trop Med Hyg. 2018 Nov;99(5):1318-1320. doi: 10.4269/ajtmh.18-0261.

PMID:
30255830
4.

Editorial: NK Cells in Human Diseases: Friends or Foes?

Vieillard V, Foley B, López-Vergès SL.

Front Immunol. 2017 Dec 7;8:1737. doi: 10.3389/fimmu.2017.01737. eCollection 2017. No abstract available.

5.

The reintroduction of DENV-2 in 2011 in Panama and subsequent outbreak characteristic.

Díaz Y, Cisneros J, Guzmán H, Cordoba P, Carrera JP, Moreno B, Chen R, Mewa JC, García L, Cerezo L, da Rosa AT, Gundacker ND, Armién B, Weaver SC, Vasilakis N, López-Vergès S, Tesh R.

Acta Trop. 2018 Jan;177:58-65. doi: 10.1016/j.actatropica.2017.09.031. Epub 2017 Oct 3.

6.

Interaction of Flavivirus with their mosquito vectors and their impact on the human health in the Americas.

Valderrama A, Díaz Y, López-Vergès S.

Biochem Biophys Res Commun. 2017 Oct 28;492(4):541-547. doi: 10.1016/j.bbrc.2017.05.050. Epub 2017 May 10. Review.

PMID:
28499872
7.

Genetic variability of human respiratory syncytial virus group B in Panama reveals a novel genotype BA14.

Ábrego LE, Delfraro A, Franco D, Castillo J, Castillo M, Moreno B, López-Vergès S, Pascale JM, Arbiza J.

J Med Virol. 2017 Oct;89(10):1734-1742. doi: 10.1002/jmv.24838. Epub 2017 May 23.

PMID:
28464479
8.

Clinical Manifestations of Punta Toro Virus Species Complex Infections, Panama, 2009.

Gundacker ND, Carrera JP, Castillo M, Díaz Y, Valenzuela J, Tamhane A, Moreno B, Pascale JM, Tesh RB, López-Vergès S.

Emerg Infect Dis. 2017 May;23(5):872-874. doi: 10.3201/eid2305.161925.

9.

Unusual pattern of chikungunya virus epidemic in the Americas, the Panamanian experience.

Carrera JP, Díaz Y, Denis B, Barahona de Mosca I, Rodriguez D, Cedeño I, Arauz D, González P, Cerezo L, Moreno L, García L, Sáenz LE, Atencio MA, Rojas-Fermin E, Vizcaino F, Perez N, Moreno B, López-Vergès S, Valderrama A, Armién B.

PLoS Negl Trop Dis. 2017 Feb 21;11(2):e0005338. doi: 10.1371/journal.pntd.0005338. eCollection 2017 Feb.

10.

A distinct innate lymphoid cell population regulates tumor-associated T cells.

Crome SQ, Nguyen LT, Lopez-Verges S, Yang SY, Martin B, Yam JY, Johnson DJ, Nie J, Pniak M, Yen PH, Milea A, Sowamber R, Katz SR, Bernardini MQ, Clarke BA, Shaw PA, Lang PA, Berman HK, Pugh TJ, Lanier LL, Ohashi PS.

Nat Med. 2017 Mar;23(3):368-375. doi: 10.1038/nm.4278. Epub 2017 Feb 6.

11.

Febrile or Exanthematous Illness Associated with Zika, Dengue, and Chikungunya Viruses, Panama.

Araúz D, De Urriola L, Jones J, Castillo M, Martínez A, Murillo E, Troncoso L, Chen M, Abrego L, Armién B, Pascale JM, Sosa N, López-Verges S, Moreno B.

Emerg Infect Dis. 2016 Aug;22(8):1515-7. doi: 10.3201/eid2208.160292. Epub 2016 Aug 15. No abstract available.

12.

Mercadeo Virus: A Novel Mosquito-Specific Flavivirus from Panama.

Carrera JP, Guzman H, Beltrán D, Díaz Y, López-Vergès S, Torres-Cosme R, Popov V, Widen SG, Wood TG, Weaver SC, Cáceres-Carrera L, Vasilakis N, Tesh RB.

Am J Trop Med Hyg. 2015 Nov;93(5):1014-9. doi: 10.4269/ajtmh.15-0117. Epub 2015 Aug 24.

13.

Chikungunya virus infection: first detection of imported and autochthonous cases in Panama.

Díaz Y, Carrera JP, Cerezo L, Arauz D, Guerra I, Cisneros J, Armién B, Botello AM, Araúz AB, Gonzalez V, López Y, Moreno L, López-Vergès S, Moreno BA.

Am J Trop Med Hyg. 2015 Mar;92(3):482-5. doi: 10.4269/ajtmh.14-0404. Epub 2015 Jan 19.

14.

CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells.

Du J, Lopez-Verges S, Pitcher BN, Johnson J, Jung SH, Zhou L, Hsu K, Czuczman MS, Cheson B, Kaplan L, Lanier LL, Venstrom JM.

Cancer Immunol Res. 2014 Sep;2(9):878-89. doi: 10.1158/2326-6066.CIR-13-0158. Epub 2014 Jun 23.

15.

NK Cells during Dengue Disease and Their Recognition of Dengue Virus-Infected cells.

Beltrán D, López-Vergès S.

Front Immunol. 2014 May 5;5:192. doi: 10.3389/fimmu.2014.00192. eCollection 2014. Review.

16.

CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection.

Milush JM, López-Vergès S, York VA, Deeks SG, Martin JN, Hecht FM, Lanier LL, Nixon DF.

Retrovirology. 2013 Dec 18;10:158. doi: 10.1186/1742-4690-10-158.

17.

Eastern equine encephalitis in Latin America.

Carrera JP, Forrester N, Wang E, Vittor AY, Haddow AD, López-Vergès S, Abadía I, Castaño E, Sosa N, Báez C, Estripeaut D, Díaz Y, Beltrán D, Cisneros J, Cedeño HG, Travassos da Rosa AP, Hernandez H, Martínez-Torres AO, Tesh RB, Weaver SC.

N Engl J Med. 2013 Aug 22;369(8):732-44. doi: 10.1056/NEJMoa1212628.

18.

Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.

Ndhlovu LC, Lopez-Vergès S, Barbour JD, Jones RB, Jha AR, Long BR, Schoeffler EC, Fujita T, Nixon DF, Lanier LL.

Blood. 2012 Apr 19;119(16):3734-43. doi: 10.1182/blood-2011-11-392951. Epub 2012 Mar 1.

19.

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.

Foley B, Cooley S, Verneris MR, Pitt M, Curtsinger J, Luo X, Lopez-Vergès S, Lanier LL, Weisdorf D, Miller JS.

Blood. 2012 Mar 15;119(11):2665-74. doi: 10.1182/blood-2011-10-386995. Epub 2011 Dec 16.

20.

Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.

Lopez-Vergès S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, Houchins JP, Miller S, Kang SM, Norris PJ, Nixon DF, Lanier LL.

Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14725-32. doi: 10.1073/pnas.1110900108. Epub 2011 Aug 8.

21.

NK cells and immune "memory".

Sun JC, Lopez-Verges S, Kim CC, DeRisi JL, Lanier LL.

J Immunol. 2011 Feb 15;186(4):1891-7. doi: 10.4049/jimmunol.1003035. Review.

22.

CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.

Lopez-Vergès S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, Norris PJ, Nixon DF, Lanier LL.

Blood. 2010 Nov 11;116(19):3865-74. doi: 10.1182/blood-2010-04-282301. Epub 2010 Aug 23.

23.

TIP47 is required for the production of infectious HIV-1 particles from primary macrophages.

Bauby H, Lopez-Vergès S, Hoeffel G, Delcroix-Genête D, Janvier K, Mammano F, Hosmalin A, Berlioz-Torrent C.

Traffic. 2010 Apr;11(4):455-67. doi: 10.1111/j.1600-0854.2010.01036.x. Epub 2010 Jan 11.

24.

Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles.

Estrabaud E, Le Rouzic E, Lopez-Vergès S, Morel M, Belaïdouni N, Benarous R, Transy C, Berlioz-Torrent C, Margottin-Goguet F.

PLoS Pathog. 2007 Jul 27;3(7):e104.

25.

The clathrin adaptor complex AP-1 binds HIV-1 and MLV Gag and facilitates their budding.

Camus G, Segura-Morales C, Molle D, Lopez-Vergès S, Begon-Pescia C, Cazevieille C, Schu P, Bertrand E, Berlioz-Torrent C, Basyuk E.

Mol Biol Cell. 2007 Aug;18(8):3193-203. Epub 2007 May 30.

26.

Luman, a new partner of HIV-1 TMgp41, interferes with Tat-mediated transcription of the HIV-1 LTR.

Blot G, Lopez-Vergès S, Treand C, Kubat NJ, Delcroix-Genête D, Emiliani S, Benarous R, Berlioz-Torrent C.

J Mol Biol. 2006 Dec 15;364(5):1034-47. Epub 2006 Oct 3.

PMID:
17054986
27.

Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions.

Lopez-Vergès S, Camus G, Blot G, Beauvoir R, Benarous R, Berlioz-Torrent C.

Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14947-52. Epub 2006 Sep 26.

28.

Supplemental Content

Loading ...
Support Center